10100597

Source:http://linkedlifedata.com/resource/pubmed/id/10100597

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0025241, umls-concept:C0031928, umls-concept:C0439237, umls-concept:C1456820, umls-concept:C1704628
pubmed:issue	5
pubmed:dateCreated	1999-4-13
pubmed:abstractText	To evaluate the feasibilitv of sequencing (based on preclinical modeling) tumor necrosis factor-a (TNF) at two dose levels with melphalan (L-PAM) and 41.8 C whole-body hyperthermia (WBH) for 60 min.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/MO1-RR03186, http://linkedlifedata.com/resource/pubmed/grant/UO1-CA 64291
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7806519
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Melphalan, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
pubmed:status	MEDLINE
pubmed:issn	0344-5704
pubmed:author	pubmed-author:AlbertiDD, pubmed-author:ArzoomanianR ZRZ, pubmed-author:FeierabendCC, pubmed-author:GillioSS, pubmed-author:GrosenEE, pubmed-author:KatschinskiD MDM, pubmed-author:KraemerCC, pubmed-author:LongeMM, pubmed-author:LoveRR, pubmed-author:MorganKK, pubmed-author:RobinsH IHI, pubmed-author:RushingDD, pubmed-author:SimonKK, pubmed-author:SpriggeJJ, pubmed-author:StewartJ AJA, pubmed-author:TiggelaarC LCL, pubmed-author:WildingGG, pubmed-author:d'OleireFF
pubmed:issnType	Print
pubmed:volume	43
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	409-14
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:10100597-Adult, pubmed-meshheading:10100597-Aged, pubmed-meshheading:10100597-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:10100597-Combined Modality Therapy, pubmed-meshheading:10100597-Feasibility Studies, pubmed-meshheading:10100597-Female, pubmed-meshheading:10100597-Humans, pubmed-meshheading:10100597-Hyperthermia, Induced, pubmed-meshheading:10100597-Male, pubmed-meshheading:10100597-Melphalan, pubmed-meshheading:10100597-Middle Aged, pubmed-meshheading:10100597-Neoplasms, pubmed-meshheading:10100597-Pilot Projects, pubmed-meshheading:10100597-Tumor Necrosis Factor-alpha
pubmed:year	1999
pubmed:articleTitle	A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermia.
pubmed:affiliation	University of Wisconsin Comprehensive Cancer Center, Madison 53792, USA.
pubmed:publicationType	Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't